Orthostatic tremor (OT) is a rare weight-bearing hyperkinetic disorder affecting station and gait. OT is characterized by unsteadiness during standing that is relieved by sitting or walking. It is confirmed on neurophysiological recording by the presence of a high-frequency tremor of 12- to 18-Hz in the legs, trunk, and sometimes, the arms, which is coherent in all muscles studied.1 It differs from other common tremor disorders by two features: its uniquely high-frequency spectrum and specific modulation in an upright stance.2 OT can be primary (idiopathic) or secondary.
A 66-year-old male presented with a 5-year history of tremor in his abdomen that only occurred when he stood in a stationary position. The tremor resolved when he sat or walked. Alcohol helped reduce the tremor severity. His symptoms had slowly exacerbated over time. There was no family history of neurological problems. His medications consisted of aspirin, dipyridamole, atorvastatin, bendroflumethiazide, and perindopril.
There was no hypomimia. He had slightly hypometric vertical saccades, but the rest of his eye movements were normal. There was minimal symmetrical postural tremor in his hands. He had visible and palpable tremor in his rectus abdominis and gastrocnemius almost immediately after standing (Video 1). The helicopter sign was positive in the abdomen but less so in the calves. He walked with a narrow gait without heel-to-shin ataxia. Deep tendon reflexes were normal, and his plantar responses were flexor. Brain magnetic resonance imaging (MRI) showed a mild degree of midline cerebellar volume loss, but his dopamine transporter scan was unremarkable.
His EMG examination showed no spontaneous activities or grouping (bursts) of motor units at rest when sitting on the bed. On standing, EMG bursts were noted at 11-12 Hz with the helicopter sign audible when the right tibialis anterior (TA) was examined. Bursts at about half the rate of TA frequency (5-6 Hz) were recorded when the external oblique and rectus abdominis were examined due to subharmonics of the high-frequency tremor spreading throughout the body.
Our case illustrates an unusual presentation of OT. Its characteristic frequency and specific appearance only during upright stance support the diagnosis. According to the literature, a sizable number of OT patients have a low-frequency (5-10 Hz) postural arm tremor,3 which may represent a subharmonic of the higher frequency tremor typical of OT (12-18 Hz),4 spreading throughout the body. In our case, the low-frequency tremor in the abdomen was attributed to the same phenomenon.
Most cases of OT (75%) are idiopathic. Primary OT appears without evidence of any underlying structural brain disorder and must be differentiated from secondary OT.2 The latter has been described in patients with essential tremor, hypokinetic-rigid syndrome, restless legs syndrome, Graves’ disease, or cerebellar atrophy.4 In our case, there was mild midline cerebellar atrophy on brain MRI, but there were no other clinical signs to suggest a secondary pathology. While the frequency of OT in this patient was slightly lower than that mentioned in the consensus statement on OT by the Movement Disorder Society,5 there is increasing evidence to suggest that OT patients with a frequency of 10-13 Hz are clinically and electrophysiologically similar to OT patients with a higher frequency range (13-18 Hz).6
The pathophysiological mechanisms underlying primary OT are not fully understood. A functional imaging study associated this condition with abnormal bilateral cerebellar and contralateral lentiform and thalamic activation.7 Another study proposed that the unsteadiness is caused by tremulous disruption of proprioceptive afferent activity from the legs, causing co-contraction of the leg muscles to increase stability. This results in increased tremor-locked muscle activity, further blocking proprioceptive input.8
Pharmacological treatment of OT has often yielded insufficient benefit. Clonazepam is probably the first-line medication as it reduces tremor in about one-third of patients.4 Second-line therapies include gabapentin, primidone, and dopaminergic drugs.
1 Funding: None.
2 Financial Disclosures: None.
3 Conflicts of Interest: The authors report no conflict of interest.
4 Ethics Statement: All patients that appear on video have provided written informed consent; authorization for the videotaping and for publication of the videotape was provided.
I would like to thank Dr. Yen Foung Tai for his expert advice and encouragement throughout this project.
Hassan, A and van Gerpen, JA (2016). Orthostatic Tremor and Orthostatic Myoclonus: Weight-bearing Hyperkinetic Disorders: A Systematic Review, New Insights, and Unresolved Questions. Tremor Other Hyperkinet Mov 6DOI: https://doi.org/10.7916/D84X584K
Schöberl, F Feil, K Xiong, G Bartenstein, P la Fougére, C Jahn, K et al. (2017). Pathological ponto-cerebello-thalamo-cortical activations in primary orthostatic tremor during lying and stance. Brain 140: 83–97, DOI: https://doi.org/10.1093/brain/aww268DOI: https://doi.org/10.1093/brain/aww268 [PubMed]
Yaltho, TC and Ondo, WG (2014). Orthostatic tremor: a review of 45 cases. Parkinsonism Relat Disord 20: 723–5, DOI: https://doi.org/10.1016/j.parkreldis.2014.03.013 [PubMed]
Benito-León, J and Domingo-Santos, A (2016). Orthostatic Tremor: An Update on a Rare Entity. Tremor Other Hyperkinet Mov 6DOI: https://doi.org/10.7916/D81N81BTDOI: https://doi.org/10.7916/D81N81BT
Deuschl, G, Bain, P and Brin, M (1998). Consensus Statement of the Movement Disorder Society on Tremor. Mov Disord 13: 2–23, DOI: https://doi.org/10.1002/mds.870131303
Rigby, HB, Rigby, MH and Caviness, JN (2015). Orthostatic Tremor: A Spectrum of Fast and Slow Frequencies or Distinct Entities?. Tremor Other Hyperkinet Mov 5DOI: https://doi.org/10.7916/D8S75FHK
Wills, AJ, Thompson, PD, Findley, LJ and Brooks, DJ (1996). A positron emission tomography study of primary orthostatic tremor. Neurology 46: 747–52, DOI: https://doi.org/10.1212/WNL.46.3.747 [PubMed]
Gerschlager, W and Brown, P (2011). Orthostatic tremor - a review. Handb Clin Neurol 100: 457–62, DOI: https://doi.org/10.1016/B978-0-444-52014-2.00035-5 [PubMed]